Clinical Trials Browser

Neoplasm Metastasis × nimotuzumab × Clear all

NCT07070479 2025-09-18

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Phase 2 Recruiting

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT00561990 2015-10-15

Nimotuzumab in Adults With Pancreatic Cancer

Phase 2/3 Completed

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms